P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia

Acta Psychiatrica Scandinavica

Volumn 117, Issue 4, 2008, Pages 313-318

  Sanchez Morla E M ^a,b   Garcia Jimenez M A ^b   Barabash, A ^c   Martinez Vizcaino V ^d   Mena, J ^b   Cabranes Diaz J A ^c   Baca Baldomero, E ^e   Santos, J L ^b  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL VIRGEN DE LA LUZ   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Bipolar disorder; P50; Psychotic symptoms; Schizophrenia; Sensory gating

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BIOLOGICAL MARKER; CLOZAPINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ANAMNESIS; ARTICLE; BIPOLAR DISORDER; CHANNEL GATING; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROBIOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SENSORY DYSFUNCTION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; BIPOLAR DISORDER; BRAIN; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DYSTHYMIC DISORDER; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 40449100092     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2007.01141.x     Document Type: Article

References (35)

1. Tsuang MT, Winokur G, Crowe RR. Morbidity risks of schizophrenia and affective disorders among first degree relatives of patients with schizophrenia, mania, depression and surgical conditions. Br J Psychiatry 1980 137 : 497 504.
2. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 2006 32 : 9 16.
3. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in post-mortem brains. Biol Psychiatry 2005 57 : 252 260.
4. Altshuler LL, Ventura J, Van Gorp WG, Green MF, Theberge DC, Mintz J. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry 2004 56 : 560 569.
5. Seidman LJ, Kremen WS, Koren D, Faraone SV, Goldstein JM, Tsuang MT. A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses. Schizophrenia Res 2002 53 : 31 44.
6. Torres J, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand 2007 116 : 17 26.
7. Selemon LD, Rajkowska G. Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder. Curr Mol Med 2003 3 : 427 436.
8. Farrow TF, Whitford TJ, Williams LM, Gomes L, Harris AW. Diagnosis- related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry 2005 58 : 713 723.
9. Mcintosh AM, Job DE, Moorhead TW, Harrison LK, Lawrie SM, Johnstone EC. White matter density in patients with schizophrenia, bipolar disorder and their unaffected relatives. Biol Psychiatry 2005 58 : 254 257.
10. Velakoulis D, Wood SJ, Wong MT et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry 2006 63 : 139 14.
11. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 1982 17 : 639 654.
12. Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biol Psychiatry 1983 18 : 537 551.
13. Bramon E, Rabe-Hesketh S, Sham P, Murria RM, Frangou S. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res 2004 70 : 315 329.
14. De Wilde OM, Bour LJ, Dingemans PN, Koelman JHTM, Linszen DH. A meta-analysis of P50 studies in patients with schizophrenia and relatives: differences in methodology between research groups. Schizphr Res 2007 97 : 137 151.
15. De Wilde OM, Bour LJ, Dingemans PN, Koelman JHTM, Linszen DH. Failure to find P50 suppression deficits in young first-episode patients with schizophrenia and clinically and unaffected siblings. Schizophr Bull 2007 33 : 1319 1323.
16. Olincy A, Martin L. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. Am J Psychiatry 2005 162 : 43 49.
17. Schulze KK, Hall MH, Mcdonald C et al. P50 auditory evoked potential suppression in bipolar disorder patients with psychotic features and their unaffected relatives. Biol Psychiatry 2007 62 : 121 128.
18. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders. New York : Biometrics Research Department, New York Psychiatric Institute, 1995.
19. Ramos-Brieva JA, Cordero-Villafáfila A. A new validation of the Hamilton Rating Scale for Depression. J Psychiatry Res 1988 22 : 21 28.
20. Colom F, Vieta E, Martínez-Arán A et al. Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale. Med Clin (Barcelona) 2002 11 : 366 371.
21. Peralta V, Cuesta MJ. Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia. Psychiatry Res 1994 53 : 31 40.
22. Van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. Arch Gen Psychiatry 1998 55 : 41 46.
23. Nagamoto HT, Adler LE, Waldo MC, Freedman R. Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biol Psychiatry 1989 25 : 549 561.
24. Raux G, Bonnet-Brilhault F, Louchart S et al. The -2 bp deletion in exon 6 of the 'alpha 7-like' nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit. Mol Psychiatry 2002 7 : 1006 1011.
25. Fielder BJ, Debus OM, Neubauer BA, Kienle M, Kurlemann G. P50 sensory gating deficit in children with centrotemporal spikes and sharp waves in the EEG. Neurosci Lett 2006 393 : 206 210.
26. White PM, Yee CM. P50 sensitivity to physical and psychological state influences. Psychophysiology 2006 43 : 320 328.
27. Fuerst DR, Gallinat J, Boutros NN. Range of sensory gating values and test-retest reliability in normal subjects. Psychophysiology 2007 44 : 620 626.
28. Adler LE, Olynci A, Cawthra EM et al. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry 2004 161 : 1822 1828.
29. Freedman R, Leonard S, Waldo M, Gault J, Olincy A, Adler LE. Characterization of allelic variants at chromosome 15q14 in schizophrenia. Genes Brain Behav 2006 5 (Suppl. 1 14 22.
30. Hong CJ, Lai IC, Liou LL, Tsai SJ. Association study of the human partially duplicated alpha7 nicotinic acetylcholine receptor genetic variant with bipolar disorder. Neurosci Lett 2004 355 : 69 72.
31. Martin LF, Leonard S, Hall MH, Tregellas JR, Freedman R, Olincy A. Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type. Am J Med Genet B Neuropsychiatr Genet 2007 144 : 611 616.
32. De Luca V, Likhodi O, Van Tol HHM, Kennedy JL, Wong AHC. Regulation of alpha 7-nicotinic receptor subunit and alpha 7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia. Acta Psychiatr Scand 2006 114 : 211 215.
33. Flomen RH, Collier DA, Osborne S et al. Association study of CHRFAM7A copy number and 2 bp deletion polymorphisms with schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 2006 141 : 571 575.
34. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull 2007 33 : 69 94.
35. Hall MH, Rijsdijk F, Kalidindi S et al. Genetic overlap between bipolar illness and event-related potentials. Psychol Med 2007 16 : 1 12.